Comparison of bicalutamide 150 mg coupled with the standard therapy and only standard methods of treatment in early prostate cancer

1. Aus G., Abbou C.C., Bolla M. et al. European Association of Urology Guidelines on Prostate Cancer. http://www.uroweb.nl/files/uploaded_files/2005ProstateCancer.pdf. Accessed November, 2005.

2. Pilepich M.V., Winter K., Lawton C.A. et al. Androgen suppression adjuvant to definitive radiotherapy in carcinomas of the prostate - long-term results of Phase III RTOG 85–31. Int J Radiat Oncol Biol Phys 2005;61:1285-90.

3. Bolla M., Collette L., Blank L. et al. Longterm results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial. Lancet 2002;360:103–6.

4. Iversen P., Tyrrell C.J., Kaisary A.V. et al. Bicalutamide monotherapy compared with castration in patients with nonmetastatic locally advanced prostate cancer: 6.3 years of followup. J Urol 2000;164:1579–82.